FPR2 and leishmaniasis: Further, it is tempting to speculate that the therapeutic success FPR2 antagonists have displayed against influenza viruses in preclinical trials could be leveraged in the fight against leishmaniasis (32), although additional pre-clinical and clinical studies are required to assess their efficacy.